Latest News
An aggressive rate-hiking cycle might be just the catalyst needed to send a historically pricey stock market past its tipping point.
Via The Motley Fool · October 16, 2026
There are risks, but the CEO sees a long runway of growth.
Via The Motley Fool · October 16, 2026
Volatus Aerospace said it has signed an agreement to acquire 100% of Lithuania-based technology company AISPECO, a transaction intended to expand its aerial intelligence capabilities across commercial infrastructure, defense, security and drone applications.
The proposed deal has base consideration
Via MarketBeat · October 16, 2026
Deckers Outdoor (NYSE:DECK): A GARP Stock With Debt-Free Growth and Attractive Valuationchartmill.com
Via Chartmill · October 16, 2026
Paysign (NASDAQ:PAYS) Shows High-Growth Leadership and Strong Momentumchartmill.com
Via Chartmill · October 16, 2026
Hamilton Lane (NASDAQ:HLNE): A GARP Candidate Built for Growth at a Reasonable Pricechartmill.com
Via Chartmill · October 16, 2026
Protagonist Therapeutics (NASDAQ:PTGX): Strong Growth Meets Constructive Technical Setupchartmill.com
Via Chartmill · October 16, 2026
The memory maker now sees more earnings a quarter than it did when its shares peaked. Has the sell-off been overdone?
Via The Motley Fool · October 16, 2026
Berkshire is moving into the homebuilding industry, but high mortgage rates have hurt the sector.
Via The Motley Fool · October 16, 2026
Its payout has hardly risen this year, but its price has surged. What does that leave for the next five years?
Via The Motley Fool · October 16, 2026
Benefits could get a nice boost, but some seniors may not get their increase in full.
Via The Motley Fool · October 16, 2026
Nebius has tripled revenue in just two years while Innodata grew at a steadier pace, but the gap between them tells a more nuanced story about growth trajectories.
Via The Motley Fool · October 16, 2026
Erdene Resource Development (TSE:ERD) said its preliminary economic assessment (PEA) for the wholly owned Zuun Mod Molybdenum-Copper Project in southwestern Mongolia outlines a potential large-scale operation with an after-tax net present value of $745 million at an 8% discount rate under its base-c
Via MarketBeat · October 16, 2026
ServiceNow commands a 2.7x revenue lead, yet both companies have posted eight consecutive quarters of growth without a single sequential decline.
Via The Motley Fool · October 16, 2026
With shares trading 56% off their peak, investors hope the rest of this year tells a different story.
Via The Motley Fool · October 16, 2026
The billionaire investor has unveiled his "master plan" to diversify this master planned community developer into an insurance and investment holding company.
Via The Motley Fool · October 16, 2026
Retirees will appreciate the bump, but is it enough?
Via The Motley Fool · October 16, 2026
Financial services giant Charles Schwab (NYSE:SCHW) met Wall Street’s revenue expectations in Q3 2026, with sales up 16.9% year on year to $7.17 billion. Its...
Via StockStory · October 16, 2026
Regional banking company First Horizon (NYSE:FHN) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 1.1% year on year to $883 million....
Via StockStory · October 16, 2026
Professional services firm Marsh (NYSE:MRSH) reported Q3 2026 results topping the market’s revenue expectations, with sales up 8.1% year on year to $6.86 bil...
Via StockStory · October 16, 2026
Workforce solutions provider ManpowerGroup (NYSE:MAN) met Wall Street’s revenue expectations in Q3 2026, with sales up 4.4% year on year to $4.84 billion. It...
Via StockStory · October 16, 2026
Financial services giant U.S. Bancorp (NYSE:USB) met Wall Street’s revenue expectations in Q3 2026, with sales up 9.5% year on year to $8.04 billion. Its non...
Via StockStory · October 16, 2026
New digital asset treasury companies, no matter how big they become, are unlikely to boost the price of XRP.
Via The Motley Fool · October 16, 2026
enGene (NASDAQ:ENGN) used a company webinar to outline preclinical findings for its investigational non-viral gene therapy, detalimogene voraplasmid, used with a polidocanol surfactant bladder rinse, while community urologists discussed the treatment burden facing patients with high-risk non-muscle
Via MarketBeat · October 16, 2026
Micron has a long history of volatility. What does the current drawdown mean for investors?
Via The Motley Fool · October 16, 2026
